This content is restricted.
Brief
On August 10, 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) issued an update regarding Government to align with European specifications on high risk in vitro diagnostic devices to reduce regulatory burden. The move aims to enhance patient safety by introducing new performance standards for IVD devices related to infectious diseases.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested